Compare KRRO & PERF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KRRO | PERF |
|---|---|---|
| Founded | 2014 | 2015 |
| Country | United States | Taiwan |
| Employees | N/A | 353 |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 150.0M | 168.1M |
| IPO Year | 2019 | N/A |
| Metric | KRRO | PERF |
|---|---|---|
| Price | $14.08 | $1.70 |
| Analyst Decision | Buy | |
| Analyst Count | 12 | 0 |
| Target Price | ★ $34.80 | N/A |
| AVG Volume (30 Days) | ★ 247.6K | 65.9K |
| Earning Date | 05-13-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $6,392,000.00 | N/A |
| Revenue This Year | N/A | $12.93 |
| Revenue Next Year | N/A | $9.44 |
| P/E Ratio | ★ N/A | $26.42 |
| Revenue Growth | ★ 181.46 | N/A |
| 52 Week Low | $5.20 | $1.24 |
| 52 Week High | $55.89 | $2.67 |
| Indicator | KRRO | PERF |
|---|---|---|
| Relative Strength Index (RSI) | 60.83 | 54.11 |
| Support Level | $10.32 | $1.68 |
| Resistance Level | $14.41 | $1.71 |
| Average True Range (ATR) | 1.32 | 0.03 |
| MACD | 0.20 | 0.00 |
| Stochastic Oscillator | 76.14 | 64.29 |
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability. The company operates and manages its business as one reportable segment and one operating segment, which is the business of discovering, developing and commercializing therapies derived from or incorporating its RNA-editing technology.
Perfect Corp is engaged in the beauty and fashion tech revolution, providing omni-channel integrated solutions. The company runs a hybrid business model of direct consumer business (B2C business) and enterprise business (B2B business). For B2C businesses, the company offers six mobile apps under the "YouCam" suite, along with one online editing service tool, YouCam Online Editor, featuring AI and AR technologies. For B2B businesses, the company offers AI and AR-powered solutions tailored for the beauty and fashion industry. Geographically, the company has a presence in the United States, Americas-other, France, Japan, and Others. The company generates the majority of its revenue from the United States.